M. Russell

发表

The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease.

P. Serruys, F. Mohr, M. J. van den Brand, 2005, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2

P. Linsley, L. Turka, M. Sayegh, 1995, The Journal of experimental medicine.

Chronic blockade of CD28-B7-mediated T-cell costimulation by CTLA4Ig reduces intimal thickening in MHC class I and II incompatible mouse heart allografts.

M. Sayegh, M. Russell, T. Glysing-Jensen, 1997, Transplantation.

Chronic cardiac rejection: identification of five upregulated genes in transplanted hearts by differential mRNA display.

M. Karnovsky, M. Russell, U. Utans, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase.

M. Mack, P. Serruys, F. Mohr, 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Investigation of Multicomponent MRI Relaxation Data with Stochastic Contraction Fitting Algorithm

M. Russell, 2014 .

Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS Clinical Trial Program.

G. Stone, S. Ellis, J. Popma, 2011, JACC. Cardiovascular interventions.

Importance of public-private partnerships for nutrition support research: An ASPEN Position Paper.

G. Sacks, V. Hubbard, F. Ottery, 2021, JPEN. Journal of parenteral and enteral nutrition.

Coronary Artery Bifurcation Lesions: Anatomy 101

I. Moussa, R. Costa, M. Russell, 2010 .

Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials.

G. Stone, G. Dangas, J. Moses, 2006, Journal of the American College of Cardiology.

Two-year serial coronary angiographic and intravascular ultrasound analysis of in-stent angiographic late lumen loss and ultrasonic neointimal volume from the TAXUS II trial.

P. Serruys, N. Bruining, D. Dudek, 2007, The American journal of cardiology.

Cardiac allograft vasculopathy – a changing perspective

M. Russell, 2000, Zeitschrift für Kardiologie.

Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial).

G. Stone, M. Leon, S. Ellis, 2005, The American journal of cardiology.

Exacerbated transplant arteriosclerosis in inducible nitric oxide-deficient mice.

J. Mudgett, M. Russell, T. Glysing-Jensen, 1998, Circulation.

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.

G. Stone, S. Ellis, C. O'shaughnessy, 2004, The New England journal of medicine.

Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV Trial.

G. Stone, M. Leon, S. Ellis, 2005, American heart journal.

Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial.

G. Stone, S. Ellis, R. Mehran, 2005, Journal of the American College of Cardiology.

Identification and upregulation of galactose/N-acetylgalactosamine macrophage lectin in rat cardiac allografts with arteriosclerosis.

R. Arceci, M. Karnovsky, M. Russell, 1994, The Journal of clinical investigation.

Influence of stent length to lesion length ratio on angiographic and clinical outcomes after implantation of bare metal and drug-eluting stents (the TAXUS-IV Study).

A. Delago, G. Stone, J. Moses, 2005, The American journal of cardiology.

Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophages.

P. Nickerson, D. Rush, M. Russell, 1999, Journal of the American Society of Nephrology : JASN.

Pivotal, randomized U.S. study of the Symbiot™ covered stent system in patients with saphenous vein graft disease: Eight‐month angiographic and clinical results from the Symbiot III trial

N. Weissman, M. Buchbinder, J. Popma, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis.

M. Sayegh, W. Hancock, M. Russell, 1996, The Journal of clinical investigation.

Echocardiography improves detection of rejection after heterotopic mouse cardiac transplantation.

M. Picard, M. Scherrer-Crosbie, M. Russell, 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Allograft inflammatory factory-1. A cytokine-responsive macrophage molecule expressed in transplanted human hearts.

B. McManus, W. Quist, R. Arceci, 1996, Transplantation.

T-cell costimulatory blockade in experimental chronic cardiac allograft rejection: effects of cyclosporine and donor antigen.

M. Sayegh, M. Russell, A. Chandraker, 1997, Transplantation.

Recipient Environment Alters Graft Rejection

A. Satoskar, M. Russell, T. Glysing-Jensen, 2013 .

Redefining peripheral tolerance in the BALB/c to CBA mouse cardiac allograft model: vascular and cytokine analysis after transient CD4 T cell depletion.

M. Russell, T. Glysing-Jensen, P. Mottram, 1998, Transplantation.

Heart transplants in interferon-gamma, interleukin 4, and interleukin 10 knockout mice. Recipient environment alters graft rejection.

A. Satoskar, M. Russell, T. Glysing-Jensen, 1997, The Journal of clinical investigation.

LEW-to-F344 carotid artery allografts: analysis of a rat model of posttransplant vascular injury involving cell-mediated and humoral responses.

M. Picard, W. Hancock, M. Russell, 1995, Transplantation.

Graft vascular disease in the great vessels and vasa vasorum.

K. Nagashima, M. Masek, M. Russell, 1993, Human pathology.

Upregulation and modulation of inducible nitric oxide synthase in rat cardiac allografts with chronic rejection and transplant arteriosclerosis.

M. Karnovsky, J. Newell, M. Russell, 1995, Circulation.

High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularization: one-year results from the SCORE randomized trial.

S. Silber, C. Di Mario, A. Lansky, 2004, Journal of the American College of Cardiology.

843-4 Reduction in late loss and restenosis in patients with small vessels treated with the slow rate-release, polymer-based paclitaxel-eluting stent: Results from TAXUS-IV

G. Stone, S. Ellis, C. O'shaughnessy, 2004 .

Effects of leflunomide and deoxyspergualin in the guinea pig-->rat cardiac model of delayed xenograft rejection: suppression of B cell and C-C chemokine responses but not induction of macrophage lectin.

F. Bach, M. Sayegh, W. Hancock, 1997, Transplantation.

Attenuated cardiac allograft vasculopathy in mice with targeted deletion of the transcription factor STAT4.

M. Russell, T. Glysing-Jensen, J. Koglin, 2000, Circulation.

Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis.

A. Satoskar, J. David, M. Russell, 1998, Journal of immunology.

Mice with STAT 6-Targeted Gene Disruption Develop a Th 1 Response and Control Cutaneous Leishmaniasis 1

A. Satoskar, J. David, M. Russell, 1998 .

Sustained anti-CD4/CD8 treatment blocks inflammatory activation and intimal thickening in mouse heart allografts.

M. Russell, T. Glysing-Jensen, A. Räisänen‐Sokolowski, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Arteriosclerosis and Peripheral Tolerance Recipients: Assessment of Transplant Cardiac Allografts from IL-4 Knockout

M. Russell, A. Räisänen‐Sokolowski, P. Mottram, 2013 .

Cardiac allografts from IL-4 knockout recipients: assessment of transplant arteriosclerosis and peripheral tolerance.

M. Russell, T. Glysing-Jensen, A. Räisänen‐Sokolowski, 1998, Journal of immunology.

Restenosis, statistics, and reasonable inferences.

G. Stone, S. Ellis, J. Popma, 2006, Journal of the American College of Cardiology.

Mechanisms of Acquired Thymic Tolerance in Experimental Autoimmtme Encephalomyelitis: Thymic Dendritic-enriched Cells Induce Specific Peripheral T Cell Unresponsiveness In Vivo By Samia J. Khoury,* Lorenzo Gallon, Wanjun Chen,*

H. Weiner, S. Khoury, M. Sayegh, 1995 .

H. Weiner, M. Sayegh, W. Hancock, 1995 .

Chronic Rejection in Experimental Cardiac Transplantation: Studies in the Lewis‐F344 Model

D. Adams, M. Karnovsky, M. Sayegh, 1993, Immunological reviews.

Early and persistent induction of monocyte chemoattractant protein 1 in rat cardiac allografts.

D. Adams, M. Karnovsky, M. Russell, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Drug-Eluting Stents in the Treatment of Intermediate Lesions

G. Stone, G. Dangas, G. Weisz, 2006 .

NOS2 mediates opposing effects in models of acute and chronic cardiac rejection: insights from NOS2-knockout mice.

J. Mudgett, M. Russell, T. Glysing-Jensen, 1998, The American journal of pathology.

Knockout models of chronic cardiac rejection and graft arteriosclerosis: intimal thickening develops independent of Th1 and Th2 cytokines.

M. Russell, T. Glysing-Jensen, A. Räisänen‐Sokolowski, 1997, Transplantation proceedings.

olymer-Based Paclitaxel-Eluting Stents educe In-Stent Neointimal Tissue Proliferation

G. Stone, C. O'shaughnessy, D. Cox, 2005 .

CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis.

R. Peach, M. Sayegh, M. Denton, 2001, The American journal of pathology.

Up-regulation of endothelin-1 mRNA and peptide expression in rat cardiac allografts with rejection and arteriosclerosis.

M. Sayegh, W. Hancock, M. Russell, 1995, The American journal of pathology.

Carotid stenting with distal protection in high surgical risk patients: The BEACH trial 30 day results

C. White, M. Russell, B. Katzen, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection.

D. Adams, N. Sibinga, M. Karnovsky, 1995, Transplantation.

Structural integrity of the glycoprotein IIb and IIIa genes in Glanzmann thrombasthenia patients from Israel.

T. Quertermous, B. Coller, P. Skoglund, 1988, Blood.

Alloimmune-mediated apoptosis: comparison in mouse models of acute and chronic cardiac rejection.

M. Russell, J. Koglin, 1999, Transplantation.

ALLOIMMUNE-MEDIATED APOPTOSIS

M. Russell, Chronic Cardiac Rejection, Org Koglin, 1999 .

Attenuated acute cardiac rejection in NOS2 -/- recipients correlates with reduced apoptosis.

B. McManus, J. Mudgett, M. Russell, 1999, Circulation.

Mechanisms of indirect allorecognition in graft rejection: class II MHC allopeptide-specific T cell clones transfer delayed-type hypersensitivity responses in vivo.

S. Khoury, M. Sayegh, M. Russell, 1996, Transplantation.

Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-gamma knockout recipients.

M. Russell, T. Glysing-Jensen, A. Räisänen‐Sokolowski, 1998, The American journal of pathology.

Immune Sources of Transforming Growth Factor-β1 Reduce Transplant Arteriosclerosis

M. Russell, T. Glysing-Jensen, A. Räisänen‐Sokolowski, 1998 .

Immune sources of transforming growth factor-beta1 reduce transplant arteriosclerosis: insight derived from a knockout mouse model.

M. Russell, T. Glysing-Jensen, A. Räisänen‐Sokolowski, 1998, Circulation research.

Macrophages in chronic rejection and graft vasculopathy: A diverse and dynamic cell with myriad roles

M. Russell, 1999 .

Graft arteriosclerosis: molecular features of macrophage activation.

M. Russell, 1997, Transplantation proceedings.

Differential mRNA Display

M. Russell, A. Räisänen‐Sokolowski, U. Utans, 1997 .

Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection.

R. Arceci, M. Russell, U. Utans, 1995, The Journal of clinical investigation.

Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trial.

G. Stone, J. Moses, M. Leon, 2005, Journal of the American College of Cardiology.

utcomes With the Paclitaxel-Eluting tent in Patients With Acute Coronary Syndromes

G. Stone, M. Leon, R. Mehran, 2005 .

TAXUS I: Six- and Twelve-Month Results From a Randomized, Double-Blind Trial on a Slow-Release Paclitaxel-Eluting Stent for De Novo Coronary Lesions

Mary E. Russell, S. Silber, K. Hauptmann, 2003, Circulation.

Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial.

G. Stone, N. Weissman, S. Ellis, 2005, Journal of the American College of Cardiology.

CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model: inhibition of cell-mediated and humoral immune responses in vivo.

M. Sayegh, W. Hancock, M. Russell, 1996, Transplantation.

Murine model of accelerated transplant arteriosclerosis.

E. Haber, J. Newell, M. Russell, 1994, Circulation research.

Hypercholesterolemia exacerbates transplant arteriosclerosis via increased neointimal smooth muscle cell accumulation: studies in apolipoprotein E knockout mice.

D. L. Fletcher, E. Haber, W. S. Lee, 1997, Circulation.

Donor and recipient contributions of ICAM-1 and P-selectin in parenchymal rejection and graft arteriosclerosis: insights from double knockout mice.

M. Russell, T. Glysing-Jensen, A. Räisänen‐Sokolowski, 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.

Gregg W Stone, G. Stone, S. Ellis, 2005, JAMA.

One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS Stent: The TAXUS-IV Trial

Gregg W Stone, G. Stone, S. Ellis, 2004, Circulation.

Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery Lesions

S. Silber, D. Dudek, A. Colombo, 2003, Circulation.

TAXUS III Trial: In-Stent Restenosis Treated With Stent-Based Delivery of Paclitaxel Incorporated in a Slow-Release Polymer Formulation

Muzaffer Degertekin, Mary E. Russell, Evelyn Regar, 2003, Circulation.

Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial.

G. Stone, S. Ellis, R. Mehran, 2006, Journal of the American College of Cardiology.

The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase.

Patrick W Serruys, A Pieter Kappetein, M. Mack, 2006, American heart journal.

Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy).

P. Teirstein, G. Stone, G. Dangas, 2005, The American journal of cardiology.

Ex vivo analysis of human coronary bifurcation anatomy: defining the main vessel-to-side-branch transition zone.

M. Russell, G. Binyamin, E. Konstantino, 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.

G. Stone, S. Ellis, L. Satler, 2006, JAMA.

Safety and efficacy of multiple, overlapping polymer-based paclitaxel-eluting stents.

N. Weissman, J. Popma, A. Colombo, 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Clinical Research Interventional Cardiology Taxus Vi 2-year Follow-up: Randomized Comparison of Polymer-based Paclitaxel-eluting with Bare Metal Stents for Treatment of Long, Complex Lesions

J. Popma, A. Colombo, G. Guagliumi, 2022 .

Peristent Remodeling and Neointimal Suppression 2 Years After Polymer-Based, Paclitaxel-Eluting Stent Implantation: Insights From Serial Intravascular Ultrasound Analysis in the TAXUS II Study

P. Serruys, D. Dudek, A. Colombo, 2005, Circulation.

Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease.

G. Stone, M. Leon, S. Ellis, 2005, Journal of the American College of Cardiology.

Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection.

D. Adams, N. Sibinga, M. Karnovsky, 1995, Transplantation.

Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.

G. Stone, S. Ellis, T. Lavelle, 2006, Journal of the American College of Cardiology.

Carotid artery revascularization in high-surgical-risk patients using the Carotid WALLSTENT and FilterWire EX/EZ: 1-year outcomes in the BEACH Pivotal Group.

W. Gray, C. White, M. Russell, 2008, Journal of the American College of Cardiology.

Clinical Efficacy of Polymer-Based Paclitaxel-Eluting Stents in the Treatment of Complex, Long Coronary Artery Lesions From a Multicenter, Randomized Trial: Support for the Use of Drug-Eluting Stents in Contemporary Clinical Practice

J. Popma, A. Colombo, G. Guagliumi, 2005, Circulation.

Leukocyte-suppressing influences of interleukin (IL)-10 in cardiac allografts: insights from IL-10 knockout mice.

M. Russell, T. Glysing-Jensen, A. Räisänen‐Sokolowski, 1998, The American journal of pathology.

Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery.

G. Stone, G. Dangas, S. Ellis, 2005, Journal of the American College of Cardiology.

utcomes of Paclitaxel-Eluting tent Implantation in Patients With Stenosis f the Left Anterior Descending Coronary Artery

G. Stone, S. Ellis, R. Shlofmitz, 2005 .

OligoclonalBandingin CerebrospinalFluidAssessedby Electrophoresison AgaroseafterCentrifugalSampleConcentrationthrougha Microconcentrator Membrane

M. Silverman, M. Russell, C. George, 2004 .

Two-year-plus follow-up of a paclitaxel-eluting stent in de novo coronary narrowings (TAXUS I).

S. Silber, K. Hauptmann, M. Russell, 2005, The American journal of cardiology.

Vascular Responses at Proximal and Distal Edges of Paclitaxel-Eluting Stents: Serial Intravascular Ultrasound Analysis From the TAXUS II Trial

R. Whitbourn, P. Serruys, C. Nienaber, 2004, Circulation.

Incomplete Stent Apposition After Implantation of Paclitaxel-Eluting Stents or Bare Metal Stents: Insights From the Randomized TAXUS II Trial

P. Serruys, N. Bruining, D. Dudek, 2005, Circulation.

Chronic Arterial Responses to Polymer-Controlled Paclitaxel-Eluting Stents: Comparison With Bare Metal Stents by Serial Intravascular Ultrasound Analyses: Data From the Randomized TAXUS-II Trial

P. Serruys, B. Strauss, M. Degertekin, 2004, Circulation.

Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV sub study).

Gregg W Stone, Issam Moussa, Michael Collins, 2005, The American journal of cardiology.

Twelve-month outcomes with a paclitaxel-eluting stent transitioning from controlled trials to clinical practice (the WISDOM Registry).

Y. Lim, H. Tan, N. Sinha, 2006, The American journal of cardiology.

Off-label use: an industry perspective on expanding use beyond approved indications.

S. Mascioli, M. Russell, M. Friedman, 2006, Journal of interventional cardiology.

DRUG-ELUTING STENTS : TAXUS-IV ender-Based Outcomes After aclitaxel-Eluting Stent Implantation n Patients With Coronary Artery Disease

G. Stone, M. Leon, R. Costa, 2005 .

Integrated analysis of medically treated diabetic patients in the TAXUS(R) program: benefits across stent platforms, paclitaxel release formulations, and diabetic treatments.

P. Serruys, G. Stone, S. Ellis, 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Modulation of inflammatory activation pathways in the Lewis-to-F-344 rat chronic cardiac rejection model.

M. Karnovsky, W. Hancock, M. Russell, 1995, Transplantation Proceedings.

Cardiac graft vascular disease. Nonselective involvement of large and small vessels.

M. Masek, M. Russell, M. Billingham, 1993, Transplantation.

The effect of diet on plasma lipids, lipoproteins, and coronary heart disease.

P. Kris-Etherton, P. Wood, D. Krummel, 1988, Journal of the American Dietetic Association.

Macrophages and transplant arteriosclerosis: known and novel molecules.

M. Russell, 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial

D. Slebos, P. Shah, J. Cooper, 2011, The Lancet.

Carotid stenting with distal protection in high surgical risk patients: The BEACH trial 30 day results

M. Russell, B. Katzen, S. Iyer, 2006 .